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Abstract
Flavonols, flavanones and flavones (FLAV) are sub-classes of flavonoids that exert cardioprotective and anti-carcinogenic properties in vitro
and in vivo. We aimed to estimate the FLAV dietary intake, their food sources and associated lifestyle factors in ten European countries
participating in the European Prospective Investigation into Cancer and Nutrition (EPIC) study. FLAV intake and their food sources for
36 037 subjects, aged between 35 and 74 years, in twenty-seven study centres were obtained using standardised 24 h dietary recall software
(EPIC-SOFT). An ad hoc food composition database on FLAV was compiled using data from US Department of Agriculture and Phenol-
Explorer databases and was expanded using recipes, estimations and flavonoid retention factors in order to increase its correspondence
with the 24 h dietary recall. Our results showed that the highest FLAV-consuming centre was the UK health-conscious group, with 130·9 and
97·0 mg/d for men and women, respectively. The lowest FLAV intakes were 36·8 mg/d in men from Umeå and 37·2 mg/d in women from
Malmö (Sweden). The flavanone sub-class was the main contributor to the total FLAV intake ranging from 46·6 to 52·9 % depending on the
region. Flavonols ranged from 38·5 to 47·3 % and flavones from 5·8 to 8·6 %. FLAV intake was higher in women, non-smokers, increased
with level of education and physical activity. The major food sources were citrus fruits and citrus-based juices (especially for flavanones),
tea, wine, other fruits and some vegetables. We concluded that the present study shows heterogeneity in intake of these three sub-classes
of flavonoids across European regions and highlights differences by sex and other sociodemographic and lifestyle factors.
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Epidemiological evidence supports claims that a high con-
sumption of fruits and vegetables is associated with lower
risk of major chronic diseases(1–3). In addition to vitamins,
minerals and fibre, polyphenolic compounds, particularly
flavonoids, have gained substantial interest in recent years as
possible contributors to these protective benefits(4,5).
The group of flavonoids comprises of more than 9000
different compounds that occur ubiquitously in the plant king-
dom(6,7). Flavonoids are classified according to their diverse
chemical structure, into seven sub-classes: flavonols, flavones,
flavanones, flavan-3-ols, proanthocyanidins, anthocyanidins
and isoflavones. In some papers, the subgroups of flavonols,
flavones and flavanones (FLAV) are also called Citrus flavo-
noids, because these are the most abundant flavonoids,
especially flavanones, in the Citrus genus (family Rustacea)(8).
Flavanones are found almost exclusively in citrus fruit and
their derived products, such as juices and jams(9). However,
flavonols are more widely distributed than flavones. Flavonols
occur in tea, onions, kale, apples, some berries, cocoa and red
wine, whereas flavones are abundant in herbs and spices
(such as parsley, fennel, oregano), artichokes, peppers and
oranges(9).
In foods, FLAV are generally found in glycosylated forms,
and their bioavailability depends on the kind of their sugar
moiety. Between 1 to 20 % of FLAV are absorbed by both
the small intestine and the colon as aglycones after being
hydrolysed by either enzymes or the microbiota with a high
intra- and inter-individuality(10,11). In the intestinal epithelial
cells, they are metabolised to glucuronides, sulfates and/or
methylates by phase II enzymes and are then released into
the bloodstream. It has been shown by animal studies that
FLAV are found in the organs of experimental animals after
ingestion, but it is still unclear whether they accumulate in
the human body. Neither the aglycones nor their glycosylated
forms have been detected in plasma or urine. Therefore, the
biological activity of FLAV may be due to their conjugated
forms, but preliminary in vitro assays have not substantiated
this enough. The other possibility is that aglycones may be
set free from their conjugates in specific tissues and exert
those effects suggested by in vitro studies(12). Finally, they
are mostly excreted in urine as conjugated forms; their bio-
logical half-life ranges from 11 to 28 h(10).
Despite their low to moderate bioavailability, results from
in vitro studies have shown that FLAV possess remarkable anti-
oxidant, anti-inflammatory, anti-carcinogenic and anti-allergic
properties(8,12–14).Moreover, some clinical and epidemiological
studies indicate that a high intake of FLAV-rich foodsmayprotect
against CVD and some kinds of cancers(15,16), but more clinical
trials with isolated FLAVare needed. The molecular mechanisms
of FLAV may underlie their ability to be linked to their ability

















to modulate enzyme activity (kinases, phospholipases, ATPases,
lipo-oxygenases, cyclo-oxygenases)(17,18).
These findings are a good starting point when assessing the
potential role of FLAV in the prevention of chronic diseases.
For this reason, an accurate estimation of exposure of these
compounds is essential in the evaluation of their potential
effects and, subsequently, in establishing any related dietary
recommendations. To date, there are few descriptive studies
assessing FLAV intakes(19–24), especially in large European
populations. The purpose of the present study was to estimate
the consumption of FLAV in ten Western European countries
participating in the European Prospective Investigation
into Cancer and Nutrition (EPIC) study. Furthermore, we
aimed to assess the most important food sources of FLAV as




The population involved in the present analysis comes from a
calibration substudy nested within the EPIC study, which was
designed to evaluate the associations between diet, lifestyle
and cancer in ten Western European countries: Denmark,
France, Germany, Greece, Italy, Norway, Spain, Sweden,
The Netherlands and the UK(25,26).
For the calibration study, a random sample stratified by
age, sex and centre, and weighted for expected cancer cases
in each stratum (36 994 subjects, approximately 8 % of the
entire EPIC cohort) completed a standardised 24 h dietary
recall (24-HDR) between 1995 and 2000(27). Participants
were mainly recruited from the general population residing
within defined geographical areas, with some exceptions:
health insurance (France), women attending breast cancer
screening (Utrecht, The Netherlands; Florence, Italy), mainly
blood donors (centres in Italy and Spain) and a cohort consist-
ing predominantly of vegetarians (the ‘health-conscious’
cohort in Oxford, UK)(26). The initial twenty-three EPIC
administrative centres were later redefined into twenty-seven
centres for the analysis of dietary patterns. Of the twenty-
seven redefined centres, nineteen have both male and
female participants, and eight recruited only women
(France; Norway; Utrecht, The Netherlands; Naples, Italy).
After exclusion of 941 subjects who were aged younger than
35 years or older than 74 years because of low participation in
these age categories, and sixteen subjects due to missing FFQ
data, a total of 36 037 subjects were finally included in this
analysis. Approval for the study was obtained from the
ethics review boards of the International Agency for Research
on Cancer (IARC) and all local EPIC participating institutions.
All participants provided written informed consent.
Dietary and lifestyle information
The 24-HDR was administered through a face-to-face
interview, except in Norway, where a telephone interview
was conducted(28). A computerised interview program
(EPIC-SOFT) was developed specifically for the calibration
study, which allowed for interview procedures to be standar-
dised across the study centres(29,30). Previous publications
have outlined in detail the rationale, methodology and popu-
lation characteristics of the 24-HDR calibration study(27,31).
Data on other lifestyle factors, including level of education,
anthropometry measures, total physical activity (combining
both occupational and leisure time activities) and smoking
history, were collected at baseline through standardised ques-
tionnaires and clinical examinations, and have been described
elsewhere(26,27,32). Also, body weight and height were mainly
self-reported by the participants during the 24-HDR interview.
The mean time interval between completion of the baseline
assessment and the 24-HDR interview varied by country,
from 1 day to 3 years later(27).
Flavonoid food composition database
In order to estimate FLAV intakes from 24-HDR, a flavonoid
food composition database (FCDB) was developed. The flavo-
nol group included isorhamnetin, kaempferol, myricetin and
quercetin. The flavone group included apigenin and luteolin.
The flavanone group included naringenin, hesperetin and
eriodictyol. FLAV are expressed as FLAV aglycones per
100 mg fresh weight and are calculated as the sum of the avail-
able forms (glycosides and aglycones) in the literature. The
FCDB is based on the most recent United States Department
of Agriculture (USDA) database on flavonoids updated in
2007(9) and expanded with values from a French database
on polyphenols, Phenol-Explorer, released in 2009(33). Both
databases gathered the most exhaustive and updated food
composition data published worldwide on flavonoids. There
are no large differences on the FLAV data between both data-
bases. Any unavailable data were estimated, as far as possible,
using flavonoid retention factors, recipes, estimations based
on similar food groups or items and logical zeros. The reten-
tion factors applied, based on data for quercetin, were 70,
35 and 25 % after frying, cooking in a microwave oven and
boiling, respectively(34). The final FCDB created contained
1877 food items and only 10 % of unknown values.
Statistical analyses
Intake results are presented as calculated least squared means
and standard errors stratified by sex and study centre and
ordered in a geographical south/north gradient. Dietary
mean intakes were calculated using general linear models
and were adjusted for age (as a continuous variable) and
weighted by season and day of the week of the 24-HDR to
control for different distributions of participants across seasons
and days of the dietary recall. The contribution of each indi-
vidual FLAV compound and each FLAV subgroup to the total
intake of both subgroup and total FLAV was calculated as
a percentage. The contribution of each food group to the
total and subgroup intake of FLAV was also calculated as a
percentage.
Differences in FLAV intake were compared according to
categories of sex, age groups, level of education, smoking

















Table 1. Adjusted* mean daily intakes of flavonols, flavanones and flavones by sex and centre ordered from south to north


























Mean SE Mean SE Mean SE Mean SE Mean SE Mean SE Mean SE Mean SE
Greece 1314 57·96 2·24 21·80 1·19 28·39 1·80 7·77 0·21 1373 47·22 2·19 15·22 1·16 27·05 1·75 4·95 0·20
Spain
Granada 214 94·21 5·54 38·39 2·94 50·28 4·44 5·55 0·52 300 70·92 4·68 20·06 2·49 45·94 3·75 4·93 0·44
Murcia 243 113·87 5·20 37·33 2·76 69·54 4·16 7·00 0·49 304 88·11 4·65 32·29 2·47 50·95 3·73 4·87 0·44
Navarra 444 85·87 3·85 35·34 2·04 45·08 3·08 5·46 0·36 271 69·71 4·92 27·04 2·62 39·60 3·94 3·07 0·46
San Sebastian 490 93·10 3·67 40·79 1·95 46·18 2·94 6·12 0·34 244 67·85 5·19 29·26 2·76 34·80 4·16 3·79 0·49
Asturias 386 64·09 4·12 26·35 2·19 33·05 3·30 4·70 0·39 324 46·69 4·50 14·53 2·39 29·55 3·61 2·61 0·42
Italy
Ragusa 168 65·73 6·25 22·79 3·32 36·13 5·01 6·80 0·59 138 47·61 6·90 15·26 3·67 25·95 5·53 6·39 0·65
Naples 403 46·18 4·04 15·19 2·15 27·34 3·23 3·65 0·38
Florence 271 58·60 4·92 24·80 2·62 28·20 3·94 5·60 0·46 784 48·31 2·89 19·54 1·54 25·07 2·32 3·70 0·27
Turin 676 70·83 3·12 30·24 1·66 32·47 2·50 8·12 0·29 392 56·90 4·09 22·79 2·18 28·60 3·28 5·51 0·38
Varese 327 73·66 4·48 27·49 2·38 37·14 3·59 9·04 0·42 794 53·78 2·88 20·00 1·53 27·75 2·30 6·03 0·27
France
South coast – – – – – – – – – 620 65·18 3·26 27·14 1·73 33·10 2·61 4·94 0·30
South – – – – – – – – – 1425 67·54 2·15 28·49 1·14 34·71 1·72 4·33 0·20
North-East – – – – – – – – – 2059 72·91 1·79 28·11 0·95 40·47 1·43 4·34 0·17
North-West – – – – – – – – – 631 75·48 3·23 27·57 1·72 43·66 2·59 4·25 0·30
Germany
Heidelberg 1034 85·47 2·52 40·48 1·34 37·81 2·02 7·19 0·24 1087 77·66 2·48 33·28 1·32 35·54 1·99 8·84 0·23
Potsdam 1233 92·92 2·31 45·05 1·23 41·52 1·85 6·36 0·22 1061 86·91 2·50 32·46 1·33 46·50 2·00 7·95 0·23
The Netherlands
Bilthoven 1024 64·33 2·55 29·13 1·36 32·77 2·05 2·44 0·24 1086 78·54 2·49 30·85 1·32 43·89 2·00 3·80 0·23
Utrecht 1870 91·58 1·88 39·72 1·00 48·62 1·51 3·24 0·18
UK
General population 403 97·61 4·04 51·01 2·15 42·85 3·24 3·76 0·38 571 88·83 3·39 42·40 1·80 43·13 2·72 3·31 0·32
Health-conscious 113 130·87 7·62 54·88 4·05 69·03 6·11 6·96 0·71 196 96·99 5·79 50·05 3·08 40·41 4·64 6·54 0·54
Denmark
Copenhagen 1356 75·44 2·20 33·81 1·17 36·68 1·76 4·95 0·21 1484 73·33 2·10 31·56 1·12 36·75 1·69 5·02 0·20
Aarhus 567 76·82 3·40 34·22 1·81 38·18 2·73 4·43 0·32 510 73·02 3·59 31·12 1·91 35·94 2·87 5·97 0·34
Sweden
Malmö 1421 37·34 2·20 18·90 1·17 16·91 1·76 1·53 0·21 1711 37·24 1·99 17·20 1·06 18·42 1·59 1·63 0·19
Umeå 1344 36·75 2·21 20·11 1·18 15·41 1·77 1·23 0·21 1574 40·32 2·04 19·81 1·09 19·02 1·64 1·50 0·19
Norway
South and East – – – – – – – – – 1004 47·49 2·58 24·17 1·37 20·03 2·07 3·29 0·24
North and West – – – – – – – – – 793 40·56 2·90 20·32 1·54 16·66 2·33 3·57 0·27
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status, level of physical activity, BMI and four European
regions (South: all centres in Greece, Spain, Italy and the
south of France; Central: all centres in the north-east and
north-west of France, Germany, the Netherlands and the gen-
eral population of the UK; North: all centres in Denmark,
Sweden and Norway; UK health-conscious population) using
general lineal models. All these models were adjusted for
sex, age (continuous), centre, BMI (continuous) and energy
intake (continuous) as well as weighted by day of the week
and season of the 24-HDR collection. All analyses were
performed using SPSS Statistics software (version 17.0; SPSS
Inc., Chicago, IL, USA).
Results
Centre-specific mean intakes of total and the subgroups of
FLAV, stratified by sex, adjusted for age, and weighted by
season and day of the week of the 24-HDR, are presented in
Table 1. For both men and women, the highest mean daily
intake of total FLAV was in the UK health-conscious group
(men 130·9 mg/d, women 97·0 mg/d) and the lowest in
Sweden (in Umeå men 36·7 mg/d, in Malmö women
37·2 mg/d). In both men and women, the highest flavonol
intake was in the two UK centres. The highest intakes of fla-
vanones were observed in men from Murcia (Spain) and the
UK health-conscious group and in women in Murcia (Spain)
and Utrecht (The Netherlands). Among males, the highest
consumption of flavones was recorded in Varese (Italy), with
the highest among females in Heidelberg (Germany). In gen-
eral, participants in Sweden had the lowest intakes of all FLAV
subgroups, except in women for flavonol (Asturias (Spain)
and Greece) and for flavanone intakes (North and West
Norway). The same analyses but for single FLAV compounds
are tabulated in Supplemental Table Annex 1 (available
online at http://www.journals.cambridge.org/bjn).
There was an increasing south–north gradient correspond-
ing to the percentage contribution of flavonol compounds to
total FLAV (ranging from 38·5 to 47·4 %). For flavanones and
flavones, a decreasing south–north gradient of percentage
contribution was shown (52·9–46·6 % and 8·6–5·8 %, respec-
tively) (Table 2). The most abundant individual FLAV were
hesperetin and quercetin, which each contributed to appro-
ximately a third of the total FLAV, followed by naringenin
(ranging from 13·3 to 20·8 %). The rest of the FLAV compounds
contributed less than 10 % in all regions.
To assess the association of some sociodemographic, life-
style and anthropometric characteristics on FLAV intakes, we
carried out stratified analyses adjusted for age, sex, centre,
energy intake and BMI (where appropriate) and weighted
by season and day of 24-HDR (Table 3). Women had statisti-
cally significant higher total FLAV, flavanone and flavone
intakes, but men consumed more flavonols. No differences
among age groups were observed in total FLAV intake. The
UK health-conscious group had the highest intake of total
and subgroups of FLAV, followed by Central, South and
North European regions. FLAV intake increased with physical
activity (P,0·001) and with level of education (P,0·001).
























































































































































































































































































































































































































































































































































































smokers than non-smokers (P,0·001). Consumption of
flavonols and flavones decreased with BMI (P,0·001), but
for total FLAV the trend was not significant.
Table 4 shows the food groups contributing to the intake of
total and subgroups of FLAV stratified by European region,
adjusted for age and sex and weighted by season and day
of 24-HDR. In all regions, fruits, vegetables, non-alcoholic
(mainly juices and tea) and alcoholic beverages (mainly
wines) accounted for approximately 90 % of FLAV intake.
Although the dietary sources of FLAV were similar, the profiles
were different; for example, in the South European region
fruits, especially citrus fruits, were the main contributors.
However, in the other regions the most abundant sources
were non-alcoholic beverages, particularly juices and tea.
The major contributors to flavonol intake (in varying pro-
portions) among regions were vegetables (leafy vegetables,
and onions and garlic), non-alcoholic beverages (tea), fruit
(apples and pears), alcoholic beverages (wine) and soups.
Combined citrus fruit and citrus fruit juice intake was by far
the main source of flavanones in all regions. Herbal tea was
the most important dietary source of flavones in the Central,
North regions and the UK health-conscious group; however,
in the South European region, wine, fruits and vegetables
were the main sources.
Discussion
To our knowledge, this is the first study that estimates the
intake of FLAV in a large European population assessing
differences among countries, sexes, age groups and other
characteristics. For the first time in 1976, Kühnau(35) estimated
the mean daily intake of the sum of all flavonoids to be
approximately 1 g, about 170 mg of which were FLAV (expre-
ssed as glycosides). This corresponds to about 115 mg/d as
flavonoid aglycones (without sugar moiety). This estimation
was based on food balance sheets and flavonoid composition
data that were obtained using an outdated analytical method-
ology; hence, the flavonoid content in foods was imprecise
and probably overestimated(19). Therefore, this first estimation
was twofold that of the present study, which ranged from
66·8 mg and 70·3 mg for men and women, respectively.
Nevertheless, FLAV intakes in some centres of the present
study were similar to those reported by Kühnau(35), such as
men in both UK centres, and Murcia (Spain), and women in
Table 3. Adjusted* mean daily intakes of flavonols, flavanones and flavones by sex and selected characteristics
(Mean values with their standard errors)
Subjects
(n)
Sum of flavonols, flavo-







Stratification variable Mean SE P † Mean SE P † Mean SE P † Mean SE P †
Sex 0·001 0·013 ,0·001 0·002
Men 13028 66·76 0·89 29·84 0·48 32·35 0·72 4·58 0·08
Women 23009 70·32 0·65 28·40 0·35 37·03 0·52 4·89 0·06
Age 0·292 ,0·001 0·237 0·004
35–44 years 3335 66·94 1·49 26·67 0·79 35·95 1·20 4·31 0·14
45–54 years 12 595 68·43 0·80 28·41 0·43 35·29 0·64 4·73 0·08
55–64 years 14 940 69·33 0·77 30·10 0·41 34·38 0·62 4·85 0·07
65–74 years 5167 67·33 1·29 29·39 0·69 33·26 1·04 4·68 0·12
European region ,0·001 ,0·001 ,0·001 ,0·001
South 11285 63·72 0·78 24·95 0·42 33·20 0·63 5·56 0·07
Central 12 679 80·73 0·75 35·22 0·40 40·45 0·60 5·07 0·07
North 11 764 50·61 0·76 24·07 0·41 23·56 0·61 2·98 0·07
UK health-conscious 309 110·10 4·64 52·17 2·46 51·21 3·71 6·73 0·44
BMI 0·205 ,0·001 0·533 ,0·001
, 25 kg/m2 16854 69·21 0·77 30·07 0·41 34·22 0·62 4·92 0·07
25 to ,30 kg/m2 13766 68·32 0·77 28·65 0·41 35·02 0·62 4·65 0·07
$ 30 kg/m2 5417 66·85 1·18 27·34 0·63 35·14 0·95 4·38 0·11
Level of schooling ,0·001 ,0·001 ,0·001 ,0·001
None 1709 67·79 2·30 27·90 1·23 35·46 1·85 4·43 0·22
Primary completed 10469 60·61 0·91 25·86 0·48 30·47 0·73 4·28 0·09
Technical/professional 8038 68·97 1·05 28·35 0·56 35·77 0·85 4·84 0·10
Secondary school 7152 70·60 1·06 29·70 0·57 36·06 0·86 4·83 0·10
University degree 8155 77·52 1·00 33·80 0·53 38·44 0·81 5·29 0·09
Smoking status ,0·001 ,0·001 ,0·001 ,0·001
Never smoker 17 483 70·88 0·74 28·92 0·40 37·16 0·60 4·80 0·07
Former smoker 10 288 70·70 0·87 31·61 0·47 34·13 0·70 4·97 0·08
Current smoker 7726 60·70 0·99 26·20 0·53 30·47 0·80 4·30 0·09
Physical activity ,0·001 0·002 0·043 ,0·001
Inactive 7463 64·58 1·50 26·75 0·80 33·28 1·20 4·54 0·12
Moderately inactive 11 969 67·60 1·37 27·74 0·73 35·11 1·10 4·76 0·09
Moderately active 8400 67·39 1·46 28·09 0·78 34·49 1·18 4·82 0·08
Active 6380 71·70 1·56 29·46 0·83 36·88 1·26 5·36 0·16
*Adjusted for sex, age, energy intake and BMI and weighted by season and day of recall.
†P value is for differences in means.

















Table 4. Percentage contributions of food groups and some main foods to the intake of flavonols, flavanones and flavones by European region*
Sum of flavonols, flavonones and
flavones (%) Flavonols (%) Flavanones (%) Flavones (%)
Food groups and foods South Central North
UK health-
conscious South Central North
UK health-
conscious South Central North
UK health-
conscious South Central North
UK health-
conscious
Potatoes and other tubers 0·5 0·7 1·3 0·5 1·4 1·7 2·9 1·0 0·0 0·0 0·0 0·0 0·0 0·0 0·0 0·0
Vegetables 17·2 8·5 9·0 7·4 38·0 17·2 17·8 14·7 1·9 0·7 0·7 0·5 21·7 12·5 8·3 7·3
Leafy vegetables 6·1 3·3 1·6 1·1 13·2 6·6 3·3 2·1 0·0 0·0 0·0 0·0 13·4 7·1 1·8 1·9
Fruiting vegetables 3·5 1·4 1·6 0·9 5·0 2·1 2·4 1·3 1·9 0·7 0·7 0·4 6·8 3·0 3·0 1·9
Root vegetables 0·1 0·2 0·3 0·1 0·3 0·3 0·3 0·2 0·0 0·0 0·0 0·0 0·2 0·8 2·1 0·4
Cabbages 0·2 0·4 1·1 0·7 0·5 0·8 2·4 1·3 0·0 0·0 0·0 0·0 0·2 0·3 0·4 0·6
Grain vegetables 0·4 0·1 0·2 0·2 1·0 0·3 0·5 0·5 0·0 0·0 0·0 0·0 0·0 0·0 0·0 0·0
Onion, garlic 5·1 2·1 3·4 2·7 13·5 4·9 7·4 6·0 0·0 0·0 0·0 0·0 0·0 0·0 0·0 0·0
Sprout vegetables 0·6 0·5 0·3 0·2 1·4 1·1 0·6 0·4 0·0 0·0 0·0 0·0 0·5 0·6 0·3 1·0
Other vegetables 1·2 0·5 0·4 1·5 3·0 1·0 0·7 3·0 0·0 0·0 0·0 0·0 0·6 0·6 0·6 1·5
Legumes 0·2 0·1 0·0 0·1 0·6 0·1 0·1 0·3 0·0 0·0 0·0 0·0 0·3 0·1 0·0 0·1
Fruits, nuts and seeds 47·8 21·5 33·0 21·7 20·2 9·6 13·1 9·1 71·0 33·0 53·7 35·4 24·3 9·1 16·1 10·2
Citrus fruits 39·1 17·0 26·8 17·1 1·3 0·5 0·8 0·5 70·3 32·4 53·2 34·5 10·3 5·2 10·4 5·9
Apples and pears 3·6 2·6 4·5 2·8 9·6 5·9 9·7 6·0 0·0 0·0 0·0 0·0 0·2 0·4 1·4 0·9
Grapes 0·7 0·3 0·3 0·3 1·6 0·7 0·6 0·6 0·0 0·0 0·0 0·0 1·4 0·9 1·0 0·8
Stone fruits 1·1 0·5 0·3 0·3 3·0 1·2 0·7 0·6 0·0 0·0 0·0 0·0 0·0 0·0 0·0 0·0
Berries 0·2 0·3 0·3 0·2 0·4 0·7 0·6 0·5 0·0 0·1 0·0 0·0 0·0 0·0 0·0 0·0
Bananas 0·0 0·0 0·0 0·0 0·0 0·0 0·0 0·0 0·0 0·0 0·0 0·0 0·0 0·0 0·0 0·0
Kiwis 0·1 0·0 0·0 0·0 0·0 0·0 0·0 0·0 0·0 0·0 0·0 0·0 0·8 0·4 0·4 0·0
Other fruits 0·3 0·1 0·0 0·1 0·2 0·0 0·0 0·2 0·7 0·6 0·5 0·9 2·0 0·5 0·4 0·5
Nuts and seeds 0·3 0·4 0·3 0·5 0·2 0·2 0·1 0·2 0·0 0·0 0·0 0·0 0·0 0·0 0·0 0·0
Olives 2·3 0·3 0·4 0·3 3·8 0·4 0·5 0·5 0·0 0·0 0·0 0·0 9·6 1·6 2·4 2·0
Dairy products 0·2 0·4 0·1 0·3 0·3 0·7 0·1 0·3 0·2 0·2 0·1 0·2 0·0 0·1 0·0 0·1
Cereal and cereal products 0·1 0·2 0·2 0·4 0·2 0·4 0·3 0·9 0·0 0·0 0·0 0·0 0·1 0·0 0·2 0·1
Meat and meat products 0·0 0·2 0·0 0·0 0·1 0·1 0·0 0·0 0·0 0·0 0·0 0·0 0·0 1·9 0·4 0·0
Fish and shellfish 0·0 0·0 0·0 0·0 0·0 0·0 0·1 0·0 0·0 0·0 0·0 0·0 0·0 0·0 0·1 0·0
Egg and egg products 0·0 0·0 0·0 0·0 0·0 0·0 0·0 0·0 0·0 0·0 0·0 0·0 0·0 0·0 0·0 0·0
Fat 0·2 0·0 0·0 0·0 0·0 0·0 0·0 0·0 0·0 0·0 0·0 0·0 1·9 0·1 0·1 0·1
Sugar and confectionery 1·1 1·8 2·5 1·1 2·4 3·5 4·6 1·9 0·3 0·5 0·9 0·4 0·3 0·3 0·6 0·3
Cakes and biscuits 0·3 0·5 0·8 0·7 0·8 0·9 1·7 1·2 0·1 0·3 0·1 0·2 0·0 0·1 0·0 0·1
Non-alcoholic beverages 16·1 51·1 38·9 56·6 11·1 37·3 40·4 50·7 19·8 61·6 37·6 61·3 15·3 59·7 38·3 64·6
Juices 10·6 32·2 18·3 30·0 0·6 2·1 1·5 1·3 19·0 60·1 35·5 59·9 1·8 12·7 6·8 12·4
Carbonated drinks 0·4 0·6 1·5 0·4 0·1 0·2 1·4 0·1 0·6 0·9 1·8 0·6 0·0 0·0 0·0 0·0
Coffee 0·2 0·6 1·3 0·5 0·6 1·4 2·8 1·1 0·0 0·0 0·0 0·0 0·0 0·0 0·0 0·0
Tea 3·4 13·5 15·6 20·9 8·8 31·2 33·5 45·5 0·0 0·0 0·0 0·0 0·7 0·7 4·0 0·0
Herbal tea 1·6 4·3 2·3 4·9 1·1 2·5 1·2 2·7 0·2 0·7 0·4 0·8 12·8 46·3 27·5 52·1
Alcoholic beverages 10·2 5·8 10·4 2·7 13·3 7·7 13·1 3·3 6·4 3·5 6·0 1·8 20·6 12·2 25·9 5·3
Wine 9·7 4·1 8·0 1·8 11·9 4·3 8·0 1·7 6·4 3·2 5·9 1·6 20·5 11·4 25·4 4·8
Beer and ciders 0·5 1·4 2·3 0·7 1·3 3·1 4·9 1·4 0·0 0·1 0·0 0·1 0·0 0·0 0·0 0·1
Spirits 0·0 0·0 0·0 0·0 0·0 0·0 0·0 0·0 0·0 0·0 0·0 0·0 0·0 0·0 0·0 0·0
Cocktails, punches 0·0 0·3 0·2 0·1 0·0 0·3 0·2 0·1 0·0 0·2 0·1 0·1 0·1 0·8 0·4 0·3
Condiments and sauces 2·2 0·8 2·3 1·5 2·2 1·1 2·8 1·4 0·2 0·2 0·9 0·2 15·1 3·9 10·0 11·7
Soups, bouillons 3·6 8·5 1·4 6·9 9·4 19·7 3·0 15·0 0·0 0·0 0·0 0·0 0·3 0·1 0·2 0·2
Soya products 0·1 0·0 0·0 0·1 0·2 0·1 0·0 0·3 0·0 0·0 0·0 0·0 0·1 0·0 0·0 0·1
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the UK health-conscious group. In 1992, Hertog et al.
developed an accurate HPLC technique to analyse flavonols
and flavones in foods(36). Since then, most of the worldwide
food composition data were generated using this technique
and have been compiled to create the actual FCDB on flavo-
noids(9,33). Although in the last decade there has been a
great increase of composition data, there are still many missing
values. Furthermore, discrepancies exist among researchers
on such topics as the application of retention factors. Hertog
et al.(19) found cooking losses lower than 20 %, but Crozier
et al.(34) showed losses of about 30, 65 and 75 % after frying,
cooking in a microwave and boiling, respectively. Each
study adopts a FCDB with slight differences in compositional
data and particularly in the estimated missing values, thus
limiting our ability to compare published results. We used
a unique FCDB containing a large number of food items
(n 1877) and few missing values (,10 %) for the entire
cohort. This reduces the underestimation and facilitates the
comparison among countries and population subgroups.
In the present study, the highest flavonol intake varied
between 3- and 4-fold among study centres in both men (from
18·9 to 54·9 mg/d) and women (from 14·5 to 50·0 mg/d). South
and North European regions had intakes of approximately
25 mg/d. This is similar to Spanish (18·7 mg/d)(23), Greek
(20·6–30·4 mg/d)(24,37,38) and Italian (21·6 mg/d)(39) studies,
but was clearly higher than that reported in other studies
such as those performed in Greece (9·6 mg/d)(40) and Finland
(5·4 mg/d)(22). The present results showed that individuals
from the Central European region consumed significantly
more flavonols (35·2 mg/d) than in the other regions. How-
ever, in the literature these values are somewhat lower; for
instance, in two Dutch studies, median intakes ranged from
21·4 to 25·9 mg/d(19,41). In other non-European countries
the results were also similar; for example, in Australia
(20·7 mg/d) and in the USA, intakes varied twofold among
studies (from 12·0 to 20·7 mg/d)(20,21,42). In the present
study, the UK health-conscious group was the highest consu-
mer group (52·2 mg/d) due to the high consumption of fruits
and vegetables in vegetarian populations. This result is
much higher than other results, but a study from the Nether-
lands also reported that the vegan group consumed more
flavonols than the general population(19). The main food
sources were basically the same in all the studies: tea,
onions and apples(19,20,22,41,42). In the present study, leafy
vegetables were also abundant dietary contributors especially
in the South European region and the group of soups and
bouillons, particularly in Central European countries, mainly
because of onion soups. Quercetin is the most important
contributor of flavonols in the present study ranging from
66 to 75 %, followed by kaempferol (15–21 %), myricetin
(6·5–11·6 %), and finally isorhamnetin (,3·3 %). This is con-
cordant with the literature(19,20,23,41).
As mentioned previously, flavanones are typically found in
citrus fruits and their derived products such as juices and jams.
In both sexes, southern Spanish centres (Murcia and Granada)
had the highest flavanone consumption because of high citrus
fruit intakes(43). The UK health-conscious group and the
Central European region also had a high flavanone intake,
but their main food source was citrus-based fruit juices. The
North European region had significantly lower flavanone
intakes, particularly the Scandinavian countries (,20mg/d)(22).
The present results in the South European region (33·2mg/d)
are in keeping with the previous results from Spain
(50·6mg/d)(23), Italy (38·3mg/d)(39) and Greece (27–58·1mg/
d)(24,37,40), but these results are clearly lower than that showed
in a Greek case–control study (106·1mg/d)(38). The intake of
flavanones in non-European countries is similar to northern
European countries, being 14·4mg/d(21) and 22·7mg/d(42) in
two US populations and 6·9mg/d(44) in Australia. The most
important flavanone contributor was hesperetin (ranging from
59·0 to 70·1%), naringenin (28·5–39·3%), and remotely followed
by eriodictyol (1·4–1·8%), depending on the European region
as in the previous studies(23,24,39,40).
Flavones were the least consumed FLAV group in all regions
(ranging from 5·8 to 8·6 %). The UK health-conscious group
had the highest intake and the North European region had
the lowest, similar to a finding in a Finnish population(22).
The South and Central European regions were intermediate
consumers(19,23,24,37–40). These differences could be attribu-
table to the variation in the main food sources. In the UK
and Central European countries the most abundant contribu-
tors were herbal teas and fruit and vegetables juices, whereas
in the South European region they were vegetables, fruits and
wine. Another food source that needs to be taken into account
is the group of condiments and sauces, because spices
and herbs are the most abundant flavone sources per 100 g
fresh matter(9,33). In comparison with other non-European
countries, the present results are higher than shown in US
(0·3–1·6 mg/d)(20,21,42) and Australian studies (0·5 mg/d)(44).
Apigenin and luteolin were the main flavones, having similar
contributions in the South and North European regions(23,24).
Luteolin is the major contributor in the UK health-conscious
group and the Central European region and the differences
can be attributed to the previously commented variations of
the main food sources among regions.
FLAV intake varied by demographic, anthropometric and
lifestyle variables. In the present study, women consumed
more flavanones and flavones than men, but fewer flavonols
as observed in the EPIC Spanish cohort(23). However, in
the Dutch study women seem to consume more flavonols
and flavones(19), while in the US study there were no statis-
tically significant sex differences(21). The group aged 55–64
years was the highest consuming group of flavonols and
flavones in the present study as in other Spanish(23), Dutch
(aged .60 years)(19) and US studies (aged 51–70 years)(21).
Flavanones were also highest in the age group of 55–64
years in the Spanish cohort(23), but in the present study
differences across age groups were not significant. The highest
consumers were subjects of normal weight (BMI ,25 kg/m2)
with a university degree, non-smokers, and those who
reported being physically active. Therefore, individuals with
a healthier lifestyle had a higher FLAV intake as was also
found in the Spanish and US study(21,23). In the Dutch study,
non-smokers and light smokers (between 1 and 9 cigarettes/d)
consumed more flavonols and flavones than heavy smokers
(.10 cigarettes/d)(19). In this study, Hertog et al. also

















showed that vegetarians had higher flavonol and flavone
intakes than non-vegetarians(19) given that all FLAV food
sources are from plants. Also in the present study, the UK
health-conscious group had higher FLAV intake than the UK
general population.
A myriad of in vitro evidence on the potential beneficial
role of FLAV in health shows that they exert a wide range of
biological activities(8,12–14). Several epidemiological studies
have also suggested beneficial effects against chronic diseases,
particularly CVD and some cancers(15,45,46). A recent meta-
analysis showed that flavonoid-rich foods and extracts have
effects on some biomarkers of cardiovascular health(15). Fur-
thermore, a recent prospective study reported that flavanones
are associated with lower CVD mortality(45). With respect
to cancer, in a meta-analysis about lung cancer the authors
concluded that high or increased intake of flavonoids is
associated with reduced cancer risk in some populations
(in males, smokers, prospective studies, and studies using
dietary history interview) but not in others(46). There are five
possible reasons for this:
(i) The dose used in the in vitro studies is normally too
high compared with tissue FLAV levels observed after
ingesting FLAV.
(ii) In vitro studies do not use FLAV metabolites, which are
the forms found in blood owing to the fact that FLAV
are heavily metabolised inside the body.
(iii) The differences in bioavailability of individual FLAV
are not taken into account in epidemiological studies.
Moreover, studies have shown a high inter- and intra-
variability in the absorption, metabolism and excretion(10).
Therefore, further studies focusing on bioavailability
and biological effects using nutritional doses of individual
FLAV are needed.
(iv) Limitations in the dietary assessment methods,
especially FFQ, should be considered(47,48).
(v) FCDB on FLAV are usually limited, containing a small
number of food items and many missing values.
Newly developed or updated FCDB(9,33) may assist in
the accurate estimation of FLAV intake and in exploring
their potential associations with chronic diseases.
This is a large study estimating the FLAV intake in ten
Western European countries. The strengths of the present
study are the large sample size (n 36 037) and the compara-
bility of these results across the countries. The results of the
present study originated from standardised single 24-HDR
and the flavonoid standardised database across all the parti-
cipating EPIC countries. However, as not all the EPIC cohorts
are population based, these findings cannot be extrapolated to
the general population of each region(49). The other limitation
of the present study is an underestimation of real FLAV intake.
This underestimation is due to the unknown composition data
(about 10 % of missing values in our FCDB) and the omission
of herb/plant supplement intake in this analysis (up to 5 %
in Denmark, the highest consumer country)(50).
In summary, the data generated in the present study
show the intakes of dietary FLAV among twenty-seven centres
in ten European countries, according to sex, age and some
lifestyle factors. These descriptive data provide a platform to
further investigate the role of FLAV in health and disease.
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